| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp | 1 | Q2 2024 | 18.7% |
| Regeneron Pharmaceuticals | 1 | Q2 2024 | 12.3% |
| Qualcomm Inc | 1 | Q2 2024 | 9.5% |
| Blueprint Medicines Corp | 1 | Q2 2024 | 4.7% |
| Ionis Pharmaceuticals Inc | 1 | Q2 2024 | 4.2% |
| Exxon Mobil Corp | 1 | Q2 2024 | 3.8% |
| Procter And Gamble Co | 1 | Q2 2024 | 3.8% |
| Biogen Inc | 1 | Q2 2024 | 3.0% |
| Abbott Labs | 1 | Q2 2024 | 2.8% |
| Parker-Hannifin Corp | 1 | Q2 2024 | 2.8% |
View Orion Investment Co's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-15 |
View Orion Investment Co's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.